Therapeutics

DiaMedica Therapeutics Inc. Appoints David Wambeke as Chief Business Officer
DiaMedica Therapeutics Inc. Appoints David Wambeke as Chief Business Officer
news.richfxm.com
11,878
Like
Save
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket
news.richfxm.com
59,966
Like
Save
Wells Fargo Assumes Autolus Therapeutics plc at Overweight
Wells Fargo Assumes Autolus Therapeutics plc at Overweight
news.richfxm.com
94,998
Like
Save
Wells Fargo Assumes Fate Therapeutics at Equal Weight
Wells Fargo Assumes Fate Therapeutics at Equal Weight
news.richfxm.com
68,261
Like
Save
Wells Fargo Assumes Alaunos Therapeutics Inc. at Overweight
Wells Fargo Assumes Alaunos Therapeutics Inc. at Overweight
news.richfxm.com
28,256
Like
Save
Wells Fargo Assumes Affimed Therapeutics at Overweight
Wells Fargo Assumes Affimed Therapeutics at Overweight
news.richfxm.com
37,687
Like
Save
BioXcel Therapeutics PT Lowered to $66 at H.C. Wainwright
BioXcel Therapeutics PT Lowered to $66 at H.C. Wainwright
news.richfxm.com
45,669
Like
Save
Karuna Therapeutics Inc. Announces Proposed $400M Stock Offering
Karuna Therapeutics Inc. Announces Proposed $400M Stock Offering
news.richfxm.com
68,535
Like
Save
Maxim Group Starts Zevra Therapeutics, Inc. at Buy
Maxim Group Starts Zevra Therapeutics, Inc. at Buy
news.richfxm.com
56,306
Like
Save
Sarepta Therapeutics announced AdCom to be held for SRP-9001
Sarepta Therapeutics announced AdCom to be held for SRP-9001
news.richfxm.com
74,183
Like
Save
Sangamo Therapeutics transferred all its $34.4 million at SVB to a new bank
Sangamo Therapeutics transferred all its $34.4 million at SVB to a new bank
news.richfxm.com
43,853
Like
Save
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
news.richfxm.com
93,848
Like
Save
Altamira Therapeutics Reports Study Showing Bentrio's Superior Nasal Residence Time and Rheological Properties
Altamira Therapeutics Reports Study Showing Bentrio's Superior Nasal Residence Time and Rheological Properties
news.richfxm.com
6,398
Like
Save
Credit Suisse Upgrades C4 Therapeutics to Neutral, 'Improved Outlook w/ Multiple Shots on Goal Post 4Q22 EPS'
Credit Suisse Upgrades C4 Therapeutics to Neutral, 'Improved Outlook w/ Multiple Shots on Goal Post 4Q22 EPS'
news.richfxm.com
21,838
Like
Save
Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing
Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing
news.richfxm.com
34,125
Like
Save
G1 Therapeutics PT Lowered to $5 at Wedbush
G1 Therapeutics PT Lowered to $5 at Wedbush
news.richfxm.com
18,464
Like
Save
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
news.richfxm.com
50,517
Like
Save
Midday movers: Horizon Therapeutics, Coupa Software, Microsoft and more
Midday movers: Horizon Therapeutics, Coupa Software, Microsoft and more
news.richfxm.com
55,130
Like
Save
Stocks making the biggest moves midday: Horizon Therapeutics, Coupa Software, Weber and more
Stocks making the biggest moves midday: Horizon Therapeutics, Coupa Software, Weber and more
news.richfxm.com

These are the stocks posting the largest moves in midday trading.

23,495
Like
Save
Amgen in Advanced Talks to Buy Horizon Therapeutics
Amgen in Advanced Talks to Buy Horizon Therapeutics
news.richfxm.com
79,240
Like
Save
Amgen in advanced talks to acquire Horizon Therapeutics – WSJ
Amgen in advanced talks to acquire Horizon Therapeutics – WSJ
news.richfxm.com
75,807
Like
Save
Horizon Therapeutics Fields Takeover Interest From Pharma Giants
Horizon Therapeutics Fields Takeover Interest From Pharma Giants
news.richfxm.com
44,645
Like
Save
Guggenheim Downgrades Neoleukin Therapeutics to Neutral
Guggenheim Downgrades Neoleukin Therapeutics to Neutral
news.richfxm.com
73,381
Like
Save
Beam Therapeutics Inc PT Lowered to $53 at Credit Suisse
Beam Therapeutics Inc PT Lowered to $53 at Credit Suisse
news.richfxm.com
18,237
Like
Save
Forex SearchClose
Copyright © RichFXM.com. Back to Forex Search